Pharmacokinetic Study of Pitavastatin and Ritonavir-Boosted Darunavir or Efavirenz

PHASE1CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

January 31, 2013

Study Completion Date

January 31, 2013

Conditions
HyperlipidemiaHIV
Interventions
DRUG

Pitavastatin

Pitavastatin 2 mg tablets taken at bedtime in Arm A and in the morning in Arm B.

DRUG

Darunavir

Darunavir 400 mg tablets x 2 taken daily in Arm B

DRUG

Ritonavir

Ritonavir 100 mg tablets taken daily in Arm B

DRUG

Efavirenz

Efavirenz 600 mg tablets taken at bedtime in Arm A

Trial Locations (1)

10016

Bellevue/NYU AIDS Clinical Trials Unit, New York

Sponsors
All Listed Sponsors
collaborator

New York City Health and Hospitals Corporation

OTHER

collaborator

Kowa Pharmaceuticals America, Inc.

INDUSTRY

collaborator

University at Buffalo

OTHER

lead

NYU Langone Health

OTHER